The Global Point of Care Diagnostics Market Valuation of $66 Billion by 2028

According to this new report, shipment of point of care test (POCT) kits is expected to increase at a CAGR of roughly 7% from 2021 to 2028. The global point of care diagnostics market was valued at $34.1 billion in 2020 and is expected to grow to $66 billion by the end of 2028.

The point of care diagnostics market has witnessed remarkable growth in recent years, driven by advancements in healthcare technology, a growing emphasis on early disease detection, and the need for rapid and convenient diagnostic solutions. Point of care diagnostics refers to medical tests conducted at or near the patient’s location, providing immediate results for clinical decision-making. This approach has revolutionized healthcare delivery by reducing turnaround times and improving patient outcomes.

Get Free Sample Copy of This Report-

Point of Care Diagnostics Market Demand & Supply Trends

  1. Rise in Chronic Diseases: The prevalence of chronic diseases, such as diabetes, cardiovascular diseases, and cancer, has surged globally. Point of care diagnostics play a vital role in monitoring these conditions, enabling timely interventions and personalized treatment plans.
  2. COVID-19 Pandemic: The COVID-19 pandemic has highlighted the importance of rapid diagnostics. Point of care tests for COVID-19 have been instrumental in identifying infected individuals quickly, facilitating isolation, and controlling the spread of the virus.
  3. Expanding Access to Healthcare: Point of care diagnostics bridge gaps in healthcare access, particularly in remote or underserved regions. They enable healthcare professionals to reach patients in rural areas, emergency settings, and resource-limited environments.
  4. Technological Advancements: Ongoing advancements in point of care diagnostic devices have led to increased accuracy, sensitivity, and specificity of tests. Miniaturization and integration of complex diagnostic processes have made point of care testing more efficient and cost-effective.
  5. Home Healthcare: With the growing trend toward home healthcare, point of care diagnostics are increasingly used by patients for self-monitoring of chronic conditions. This empowers individuals to actively manage their health.
  6. Diverse Test Panels: Point of care diagnostics encompass a wide range of tests, including blood glucose monitoring, cardiac markers, infectious disease tests, and pregnancy tests. The market continues to expand with new test panels catering to various healthcare needs.

Key Companies Profiled In This Report

  • Hoffmann-La Roche Ltd.
  • Johnson & Johnson Services Inc.
  • bioMérieux SA
  • Nova Biomedical
  • Siemens AG
  • Danaher Corporation
  • Cardinal Health Inc.
  • Thermo Fisher Scientific Inc.
  • Bio-Rad Laboratories Inc.
  • BD
  • Abbott

Point of Care Diagnostics Market Current Issues and Challenges

  • Regulatory Compliance: Ensuring that point of care diagnostic devices meet stringent regulatory requirements can be challenging for manufacturers. Compliance with quality standards and regulations is essential for product approval and market entry.
  • Quality Control: Maintaining consistent quality and accuracy of point of care tests across different settings and operators is a critical concern. Manufacturers must implement robust quality control measures.
  • Data Management: Effective data management and integration of point of care test results into electronic health records (EHRs) and healthcare systems can be complex. Interoperability issues need to be addressed.
  • Affordability: Despite advancements, some point of care diagnostic tests can still be costly. Ensuring affordability and accessibility, especially in low-income regions, remains a challenge.
  • Training and Education: Healthcare professionals and patients need adequate training to perform and interpret point of care tests correctly. Education programs are essential for effective implementation.
  • Supply Chain and Distribution: Maintaining a stable supply chain for point of care diagnostic devices and ensuring timely distribution to healthcare facilities are logistical challenges, especially during emergencies.
  • Test Accuracy: While point of care tests offer rapid results, maintaining high accuracy, particularly for complex tests, is an ongoing challenge that manufacturers must address.

Competitive Landscape:

Prominent providers of point of care diagnostic solutions are strategically leveraging mergers and acquisitions to bolster their global market presence and accelerate their product development and research initiatives.

Recent Example:

In September 2021, LumiraDx Limited, a leading provider of next-generation point of care diagnostic solutions, successfully finalized a merger agreement that had been previously negotiated with CA Healthcare Acquisition Corp. This special purpose acquisition entity, headquartered in the United States, has enabled LumiraDx to strengthen its market position and expedite its efforts in product development and research. This strategic move underscores the commitment of key players in the industry to enhance their capabilities and broaden their reach in the competitive landscape of point of care diagnostics.

Key Segments Covered in Point of Care Diagnostics Industry Research

  • By Platform:
    • Lateral Flow Assays-based POC Tests
    • Dipsticks POC
    • Microfluidic Point of Care Testing
    • Molecular Diagnostics
    • Immunoassay Technology
    • Others
  • By Application:
    • Glucose Monitoring Products
    • Cardiometabolic Monitoring Products
    • Infectious Disease Testing Products
    • Pregnancy & Fertility Testing Products
    • Urinalysis Testing Products
    • Cholesterol Testing Products
    • Hematology Testing Products
    • Drugs-of-abuse Testing Products
    • Others
  • By End User:
    • Hospitals
    • Diagnostic Laboratories
    • Clinics/Physician Offices
    • Home Care
    • Others
  • By Region:
    • North America
    • Latin America
    • Europe
    • East Asia
    • South Asia & Oceania
    • MEA

Get Customization on this Report for Specific Research Solutions –

The point of care diagnostics market is evolving rapidly to meet the changing demands of healthcare. As technology continues to advance and the importance of rapid, accessible diagnostics grows, addressing regulatory compliance, quality control, data management, affordability, and training will be pivotal in shaping the future of point of care diagnostics and improving healthcare outcomes worldwide.

About Fact.MR

Fact.MR is a market research and consulting agency with deep expertise in emerging market intelligence. Spanning a wide range – from automotive & industry 4.0 to healthcare, technology, chemical and materials, to even the most niche categories.

US Sales Office
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583, +353-1-4434-232